Is chemoimmunotherapy a game changer in the treatment of locally advanced head and neck squamous cell carcinoma?

Pembrolizumab and chemotherapy (chemoimmunotherapy) were administered to 2 head and neck squamous cell carcinoma (HNSCC) patients with extremely advanced local tumors and distant metastases with palliative intent. However, they demonstrated strikingly good responses and achieved remission. Expanded...

Descripción completa

Detalles Bibliográficos
Autores principales: Masuda, Muneyuki, Nagata, Ryozaburo, Hara, Hirotaka, Kuroki, Keiji, Sato, Kuniaki, Rikimaru, Fumihide, Toh, Satoshi, Higaki, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457411/
https://www.ncbi.nlm.nih.gov/pubmed/34584700
http://dx.doi.org/10.1002/ccr3.4793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457411/
https://www.ncbi.nlm.nih.gov/pubmed/34584700
http://dx.doi.org/10.1002/ccr3.4793

Ejemplares similares